VENTAS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.91 USD | +0.41% |
|
+2.86% | -1.87% |
| 05-16 | Scotiabank Adjusts Price Target on Ventas to $51 From $47 | MT |
| 05-16 | Morgan Stanley Adjusts Price Target on Ventas to $49 From $47, Keeps Equalweight Rating | MT |
Presenter SpeechJohn Kim (Analysts)We're good. Okay. Thank you for coming to this presentation...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Sector
Specialized REITs
Calendar
31/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
48.91
USD
Average target price
53.26
USD
Spread / Average Target
+8.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.87% | 19.72B | |
| +12.32% | 60.36B | |
| +0.45% | 14.05B | |
| -0.10% | 7.58B | |
| -6.79% | 6.08B | |
| +12.06% | 3.53B | |
| +0.46% | 3.35B | |
| -4.32% | 3.2B | |
| +2.04% | 3.07B | |
| +19.09% | 2.89B |
- Stock Market
- Equities
- VTR Stock
- News Ventas, Inc.
- Transcript : Ventas, Inc. Presents at NAREIT's REITweek
